Breaking News

Little change after landmark report on racism in medicine; Omada aims to corner the chronic disease market

 

Daily Recap

20 years ago, a landmark report spotlighted systemic racism in medicine. Why has so little changed?

By Usha Lee McFarling

André Chung for STAT

The 2002 report sent shock waves through medicine. But today, health disparities and the structural racism underlying them remain.

Read More

STAT+: Hedged in by rivals, Omada looks to corner the market for virtual chronic disease care

By Katie Palmer

Adobe

Omada — which has expanded rapidly into virtual care for chronic diseases — faces stiff competition from rivals like Livongo and Onduo.

Read More

Scientists take key step toward unraveling the genetic roots of ALS in a pair of studies

By Jonathan Wosen

Adobe

Teams led by scientists at Stanford and University College London made essentially the same discovery on ALS at the same time.

Read More

Opinion: What I learned from Paul Farmer: Treat the systems around the patient, not just the disease

By Junaid Nabi

Dieu Nalio Chery/AP

Paul Farmer taught others to work toward treating the systems that surround patients, and not just the diseases they had.

Read More

STAT+: Regulatory warnings about drugs are tied to modest drops in prescribing

By Ed Silverman

Adobe

Around 50% of adverse events that send people to emergency departments or hospitals are preventable, said co-author Barbara Mintzes.

Read More

Opinion: Listen: How a scientist turns into a medical misinformant

By Patrick Skerrett

This week on "The First Opinion Podcast," science journalist Faye Flam talks about medical misinformation, emotional manipulation, and lies.

Read More

Opinion: A preacher's new calling: Connecting neuroscience researchers as a way to advance social justice

By Rev. Alvin C. Hathaway Sr.

Evelyn J. Chatmon

That mental illnesses are more common in people of African ancestry is one reason why neuroscience needs more African American researchers.

Read More

STAT+: FDA asks Congress for more power to regulate certain diagnostic tests, including prenatal screenings

By Nicholas Florko

Jacquelyn Martin/AP

The FDA wants clearer authority over certain diagnostic tests, including prenatal screenings for genetic issues.

Read More

Wednesday, February 23, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments